CNTB

Connect Biopharma Holdings Limited

1.55 USD
+0.30 (+24.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Connect Biopharma Holdings Limited stock is down -7.74% since 30 days ago. The next earnings date is Sep 10, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 July’s closed higher than June.

About Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. Its products also comprise CBP-307, a small molecule modulator of sphingosine 1-phosphate receptor 1, a regulator of T cell mobilization out of lymph nodes. The company was founded in 2012 and is headquartered in Taicang, China.